Please assess the completion status of the following clinical trial:

Trial Title: Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line Chemotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A primary histopathological and/or cytopathological diagnosis of small cell lung cancer (SCLC)~* Diagnosis of extensive stage disease (extensive stage \[ES\]-SCLC), with stage established by computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET) scan~* Scheduled to receive front-line platinum-based chemotherapy with carboplatin or cisplatin plus etoposide~* Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document~Exclusion Criteria:~* No recent chemotherapy or surgery, as defined as in the last 6 months~* Presence of a pacemaker or defibrillator~* Patients with major chronic disease known to adversely affect PA, including human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), congestive heart failure, tuberculosis~* Patients with body mass index (BMI) greater than 34 or less than 16~* Any condition or abnormality which may, in the opinion of the investigator, compromise the safety of patients~* Unable or unwilling to follow protocol requirements~* Pregnant women are excluded from participation due to inability to participate in required chemotherapy regimen

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (bioelectric impedance analysis) (Type: EXPERIMENTAL): Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).